Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.20
+0.25 (2.79%)
Jun 9, 2026, 4:00 PM EDT - Market closed

Bioventus Revenue

Bioventus had revenue of $132.09M in the quarter ending March 28, 2026, with 6.63% growth. This brings the company's revenue in the last twelve months to $576.30M, up 1.52% year-over-year. In the year 2025, Bioventus had annual revenue of $568.09M, down -0.91%.

Revenue (ttm)
$576.30M
Revenue Growth
+1.52%
P/S Ratio
1.33
Revenue / Employee
$613,085
Employees
940
Market Cap
768.52M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025568.09M-5.19M-0.91%
Dec 31, 2024573.28M60.94M11.89%
Dec 31, 2023512.35M228.00K0.04%
Dec 31, 2022512.12M81.22M18.85%
Dec 31, 2021430.90M109.74M34.17%
Dec 31, 2020321.16M-18.98M-5.58%
Dec 31, 2019340.14M20.96M6.57%
Dec 31, 2018319.18M65.53M25.83%
Dec 31, 2015253.65M10.76M4.43%
Dec 31, 2014242.89M10.52M4.53%
Dec 31, 2013232.38M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
QuidelOrtho2.66B
CONMED1.37B
Lumexa Imaging Holdings1.03B
Artivion458.69M
InMode374.64M
Tactile Systems Technology343.52M
SI-BONE206.22M
Beta Bionics110.24M
Revenue Rankings